Debt-to-Equity

Amid rising flash costs and hardware shortages, one company's record quarter reveals a new, urgent mandate for efficiency and flexibility in IT.

A top financial forum is urging a GST hike, corporate tax cuts, and a radical revamp of retirement savings in its bold 2026 federal budget proposal.

MBX Biosciences prepares for the Jefferies conference, with investors eyeing updates on its late-stage hypoparathyroidism drug and promising obesity portfolio.

EastGroup Properties announced its 186th straight dividend, a testament to its financial stability and the enduring resilience of industrial real estate.

With booming revenue and a new premium product on the horizon, Grindr's CFO is set to outline the company's ambitious future to investors this month.

After unprecedented growth, Clear Fork Bank names a new CEO known for community ties, signaling a strategy to blend legacy values with future expansion.

Dream Finders Homes escalates its takeover attempt of Beazer Homes with a public offer, citing a decade of underperformance and a failing strategy.

Advanced Drainage Systems raises its dividend, reflecting robust financial health and a strategy balancing shareholder rewards with strategic growth investments.

With final court approval, Crescita Therapeutics will be delisted from the TSX as global platform ClinActiv snaps up its dermatology assets.

Celebrating a half-century of progress, Liberty Hill Foundation's anniversary gala was an urgent plea to fund the fight for Los Angeles's future.

CFO Martin Fischer's reappointment secures leadership continuity, reinforcing Fresenius Medical Care's focus on financial discipline and long-term growth.

Strong glaucoma sales and disciplined spending helped Iridex narrow its quarterly loss, signaling resilience despite retina segment woes and global headwinds.

Following a record year of profit and growth, the French diagnostics firm secures a major analyst endorsement, signaling a powerful turnaround. What's next?

A $290M war chest fuels a new public biotech aiming to help millions of migraine patients who don't respond to current blockbuster therapies.

The nation's largest EMS provider, GMR Solutions, saw its stock surge on its NYSE debut after a major IPO price cut to appease wary investors.

The firm reported a 3.7% drop in net asset value and a net loss for Q1 2026, raising questions about its dividend sustainability despite a stable payout.

TSLX prices a $300M bond offering and plans a strategic swap to manage risk, signaling confidence and enhancing its firepower in private credit.

A Florida rehab is trading therapy sessions for guitar lessons and open mics, offering patients an innovative and creative new path to long-term sobriety.

Over half of Adecco Group's shareholders chose new shares over cash, allowing the firm to retain CHF 79 million for its strategic tech and debt goals.

SCHMID Group reaffirms its ambitious 2026 forecast despite a slow start, banking on China's momentum and a major debt-for-equity conversion.